Continued losses in recent years have forced GlaxoSmithKline to close its medicine manufacturing unit in Bangladesh after over six decades of operation.

Supreme Court upholds a High Court order that directed the government to halt production of 20 pharmaceutical companies for manufacturing substandard drugs. The apex court also asks the HC to hear and dispose of the rule over legality of the government’s inaction to stop production of the 20 companies by August 18.